EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase – Here’s Why

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares saw unusually-strong trading volume on Monday . Approximately 444,375 shares were traded during mid-day trading, an increase of 775% from the previous session’s volume of 50,775 shares.The stock last traded at $161.29 and had previously closed at $162.38.

Wall Street Analysts Forecast Growth

ESLOY has been the subject of a number of research reports. Zacks Research downgraded EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. UBS Group raised EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a report on Friday, December 5th. Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. Finally, Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy”.

EssilorLuxottica Stock Performance

The company has a debt-to-equity ratio of 0.18, a current ratio of 0.97 and a quick ratio of 0.67. The firm has a 50-day moving average price of $171.14 and a 200 day moving average price of $161.26.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.